Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3481)
Intellia Therapeutics, Inc. (NTLA)
BASTA JAMES — EVP, General Counsel
Shares
10,397
Price
$9.21
Total Value
$95.76K
Shares Held After
101,528
% of Holdings
9.3%
Intellia Therapeutics, Inc. (NTLA)
Lebwohl David — EVP, Chief Medical Officer
Shares
11,903
Price
$9.21
Total Value
$109.63K
Shares Held After
121,249
% of Holdings
8.9%
Intellia Therapeutics, Inc. (NTLA)
LEONARD JOHN M — Director
Shares
34,146
Price
$9.21
Total Value
$314.48K
Shares Held After
1,013,339
% of Holdings
3.3%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
2,031
Price
$40.18
Total Value
$81.61K
Shares Held After
86,756
% of Holdings
2.3%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
29,670
Price
$21.34
Total Value
$633.16K
Shares Held After
924,393
% of Holdings
3.1%
Intellia Therapeutics, Inc. (NTLA)
Cohen Fred E — Director
Shares
150,000
Price
$9.35
Total Value
$1.40M
Shares Held After
207,453
% of Holdings
72.3%
Intellia Therapeutics, Inc. (NTLA)
Clark Eliana — EVP, Chief Technical Officer
Shares
9,515
Price
$9.21
Total Value
$87.63K
Shares Held After
87,118
% of Holdings
9.8%
Intellia Therapeutics, Inc. (NTLA)
Dulac Edward J III — EVP, Chief Financial Officer
Shares
6,379
Price
$9.21
Total Value
$58.75K
Shares Held After
99,683
% of Holdings
6.0%
Intellia Therapeutics, Inc. (NTLA)
Dube Michael P — VP, Chief Accounting Officer
Shares
2,989
Price
$9.21
Total Value
$27.53K
Shares Held After
52,277
% of Holdings
5.4%
Intellia Therapeutics, Inc. (NTLA)
Schultes Birgit C — EVP, Chief Scientific Officer
Shares
8,508
Price
$9.21
Total Value
$78.36K
Shares Held After
98,533
% of Holdings
7.9%
INCYTE CORP (INCY)
Stein Steven H — EVP & Chief Medical Officer
Shares
15,634
Price
$101.70
Total Value
$1.59M
Shares Held After
34,203
% of Holdings
31.4%
Actuate Therapeutics Inc (ACTU)
THOMSON TODD S — Director
Shares
280,000
Price
$5.80
Total Value
$1.62M
Shares Held After
904,795
% of Holdings
23.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
2,000
Price
$70.25
Total Value
$140.50K
Shares Held After
40,123
% of Holdings
4.7%
Xeris Biopharma Holdings, Inc. (XERS)
Shannon John Patrick Jr — Director
Shares
24,907
Price
$7.08
Total Value
$176.26K
Shares Held After
2,705,346
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
50
Price
$495.01
Total Value
$24.75K
Shares Held After
370
% of Holdings
11.9%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
3,670
Price
$10.35
Total Value
$37.98K
Shares Held After
160,722
% of Holdings
2.2%
Apellis Pharmaceuticals, Inc. (APLS)
Baumal Caroline — Chief Medical Officer
Shares
3,020
Price
$25.53
Total Value
$77.10K
Shares Held After
91,206
% of Holdings
3.2%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
4,625
Price
$61.24
Total Value
$283.24K
Shares Held After
207,497
% of Holdings
2.2%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
3,150
Price
$22.84
Total Value
$71.95K
Shares Held After
91,996
% of Holdings
3.3%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Director
Shares
10,312
Price
$7.60
Total Value
$78.37K
Shares Held After
88,020
% of Holdings
10.5%
Xilio Therapeutics, Inc. (XLO)
Frankenfield Christopher James — Chief Financial Officer
Shares
7,030
Price
$0.64
Total Value
$4.52K
Shares Held After
24,766
% of Holdings
22.1%
Vir Biotechnology, Inc. (VIR)
SATO VICKI L — Director
Shares
22,000
Price
$5.93
Total Value
$130.38K
Shares Held After
1,166,391
% of Holdings
1.9%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
540
Price
$101.47
Total Value
$54.79K
Shares Held After
49,086
% of Holdings
1.1%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
5,455
Price
$100.77
Total Value
$549.70K
Shares Held After
49,626
% of Holdings
9.9%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
4,005
Price
$100.03
Total Value
$400.62K
Shares Held After
55,081
% of Holdings
6.8%
Xilio Therapeutics, Inc. (XLO)
Brennan Kevin M. — SVP, FINANCE AND ACCOUNTING
Shares
1,826
Price
$0.64
Total Value
$1.17K
Shares Held After
6,371
% of Holdings
22.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
200
Price
$489.15
Total Value
$97.83K
Shares Held After
36,781
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,181
Price
$487.76
Total Value
$1.06M
Shares Held After
36,981
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,130
Price
$486.85
Total Value
$550.14K
Shares Held After
39,162
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,509
Price
$485.68
Total Value
$732.89K
Shares Held After
40,292
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,240
Price
$484.54
Total Value
$600.82K
Shares Held After
41,801
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
739
Price
$483.35
Total Value
$357.20K
Shares Held After
43,041
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
479
Price
$481.83
Total Value
$230.80K
Shares Held After
43,780
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
822
Price
$481.26
Total Value
$395.60K
Shares Held After
44,259
% of Holdings
1.8%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
4,015
Price
$5.73
Total Value
$23.01K
Shares Held After
766,480
% of Holdings
0.5%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
18,568
Price
$0.63
Total Value
$11.70K
Shares Held After
2,472,297
% of Holdings
0.7%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
885
Price
$63.16
Total Value
$55.90K
Shares Held After
50,440
% of Holdings
1.7%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
2,062
Price
$44.93
Total Value
$92.65K
Shares Held After
6,000
% of Holdings
25.6%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
37,938
Price
$44.40
Total Value
$1.68M
Shares Held After
8,062
% of Holdings
82.5%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
1,108
Price
$29.75
Total Value
$32.97K
Shares Held After
205,084
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
3,144
Price
$29.08
Total Value
$91.43K
Shares Held After
206,192
% of Holdings
1.5%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
8,748
Price
$28.17
Total Value
$246.40K
Shares Held After
209,336
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
CAUSEY CHRISTOPHER — Director
Shares
1,000
Price
$500.01
Total Value
$500.01K
Shares Held After
4,190
% of Holdings
19.3%
LeonaBio, Inc. (LONA)
Worthington Mark — General Counsel and CCO
Shares
876
Price
$6.88
Total Value
$6.03K
Shares Held After
13,978
% of Holdings
5.9%
LeonaBio, Inc. (LONA)
CHURCH KEVIN — CHIEF SCIENTIFIC OFFICER
Shares
876
Price
$6.88
Total Value
$6.03K
Shares Held After
20,681
% of Holdings
4.1%
LeonaBio, Inc. (LONA)
Renninger Robert — Chief Financial Officer
Shares
297
Price
$6.88
Total Value
$2.04K
Shares Held After
12,857
% of Holdings
2.3%
LeonaBio, Inc. (LONA)
Litton Mark James — Director
Shares
2,586
Price
$6.88
Total Value
$17.79K
Shares Held After
40,828
% of Holdings
6.0%
LeonaBio, Inc. (LONA)
San Martin Javier — CHIEF MEDICAL OFFICER
Shares
1,644
Price
$6.88
Total Value
$11.31K
Shares Held After
10,189
% of Holdings
13.9%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
1,157
Price
$79.27
Total Value
$91.72K
Shares Held After
37,793
% of Holdings
3.0%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
4,993
Price
$78.62
Total Value
$392.57K
Shares Held After
38,950
% of Holdings
11.4%
Showing 3101–3150 of 3481 transactions (page 63 of 70)